May 7 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.26 4.61 4.60 2.23
(-7.6 pct) (-1.3 pct) (+8.0 pct) (+6.9 pct)
Operating 632 mln 608 mln 600 mln 300 mln
(+3.9 pct) (+4.7 pct) (-5.1 pct) (-6.4 pct)
Recurring 653 mln 616 mln 600 mln 300 mln
(+6.1 pct) (+3.3 pct) (-8.2 pct) (-8.0 pct)
Net 417 mln 398 mln 400 mln 200 mln
(+4.7 pct) (+3.3 pct) (-4.2 pct) (-0.5 pct)
EPS 100.63 yen 97.09 yen 97.71 yen 48.86 yen
Ann Div 15.00 yen 15.00 yen 15.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 15.00 yen 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T